261 related articles for article (PubMed ID: 15022343)
1. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.
Sumariwalla PF; Gallily R; Tchilibon S; Fride E; Mechoulam R; Feldmann M
Arthritis Rheum; 2004 Mar; 50(3):985-98. PubMed ID: 15022343
[TBL] [Abstract][Full Text] [Related]
2. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
Malfait AM; Gallily R; Sumariwalla PF; Malik AS; Andreakos E; Mechoulam R; Feldmann M
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9561-6. PubMed ID: 10920191
[TBL] [Abstract][Full Text] [Related]
3. Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
Baharav E; Bar-Yehuda S; Madi L; Silberman D; Rath-Wolfson L; Halpren M; Ochaion A; Weinberger A; Fishman P
J Rheumatol; 2005 Mar; 32(3):469-76. PubMed ID: 15742438
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
Sumariwalla PF; Palmer CD; Pickford LB; Feldmann M; Foxwell BM; Brennan FM
Rheumatology (Oxford); 2009 Jan; 48(1):32-8. PubMed ID: 19015145
[TBL] [Abstract][Full Text] [Related]
5. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Chen J; Zhang XM; Xu Q
Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
[TBL] [Abstract][Full Text] [Related]
6. HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.
Haj CG; Sumariwalla PF; Hanuš L; Kogan NM; Yektin Z; Mechoulam R; Feldmann M; Gallily R
J Pharmacol Exp Ther; 2015 Oct; 355(1):66-75. PubMed ID: 26272937
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
Hai le X; Kogure T; Niizawa A; Fujinaga H; Sakakibara I; Shimada Y; Watanabe H; Terasawa K
J Rheumatol; 2002 Aug; 29(8):1601-8. PubMed ID: 12180716
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C
Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
[TBL] [Abstract][Full Text] [Related]
11. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
13. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
14. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
15. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action.
Malfait AM; Malik AS; Marinova-Mutafchieva L; Butler DM; Maini RN; Feldmann M
J Immunol; 1999 May; 162(10):6278-83. PubMed ID: 10229875
[TBL] [Abstract][Full Text] [Related]
16. (5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA/1 mice via suppressing interferon-gamma production and its related signaling.
Zhou R; Tang W; Ren YX; He PL; Zhang F; Shi LP; Fu YF; Li YC; Ono S; Fujiwara H; Yang YF; Zuo JP
J Pharmacol Exp Ther; 2006 Jul; 318(1):35-44. PubMed ID: 16574782
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
19. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
20. Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvant arthritic rats.
Yamamoto N; Sakai F; Yamazaki H; Kawai Y; Nakahara K; Okuhara M
J Rheumatol; 1996 Oct; 23(10):1778-83. PubMed ID: 8895158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]